APA Citatie

Ference, B. A., Cannon, C. P., Landmesser, U., Lüscher, T. F., Catapano, A. L., & Ray, K. K. (2018). Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: An analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration. Eur Heart J.

Chicago Style citaat

Ference, Brian A., Christopher P. Cannon, Ulf Landmesser, Thomas F. Lüscher, Alberico L. Catapano, en Kausik K. Ray. "Reduction of Low Density Lipoprotein-cholesterol and Cardiovascular Events With Proprotein Convertase Subtilisin-kexin Type 9 (PCSK9) Inhibitors and Statins: An Analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration." Eur Heart J 2018.

MLA citatie

Ference, Brian A., et al. "Reduction of Low Density Lipoprotein-cholesterol and Cardiovascular Events With Proprotein Convertase Subtilisin-kexin Type 9 (PCSK9) Inhibitors and Statins: An Analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration." Eur Heart J 2018.